Literature DB >> 9873214

Hyperuricemic nephropathies.

T H Steele1.   

Abstract

This review explores the relationship between uric acid or urate and the pathogenesis of renal impairment. The following points and conclusions are emphasized: (1) uric acid is an end product of purine degradation in humans and normally depends upon renal excretion for the majority of its elimination from the body; (2) massive urate overproduction - usually occurring acutely because of tumor lysis, rhabdomyolysis, or some other cause of rapid nucleic acid turnover or tissue destruction - tends to cause acute renal failure because of an increase of intratubular uric acid precipitation and obstruction; (3) chronic urate overproduction (with increased urate excretion) is more likely to be associated with stones or gout than with acute renal failure; (4) chronic asymptomatic hyperuricemia is unlikely to cause renal disease, gout, or stones, but is associated with cardiovascular impairment over the long term, and (5) asymptomatic hyperuricemia may serve as an indicator of renal vascular disease, or, to the extent that it may reflect insulin-induced acceleration of renal tubule urate reabsorption, hyperuricemia may serve as an indicator of insulin resistance. Therefore chronic asymptomatic hyperuricemia may predict the adverse cardiovascular consequences of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9873214     DOI: 10.1159/000046298

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  10 in total

Review 1.  Pathogenesis of hyperuricemia: recent advances.

Authors:  Manisha Ghei; Mihaela Mihailescu; Dennis Levinson
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

Review 2.  Hyperuricemia and renal function.

Authors:  L M Ruilope; J Garcia-Puig
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 3.  The role of uric acid as an endogenous danger signal in immunity and inflammation.

Authors:  Faranak Ghaemi-Oskouie; Yan Shi
Journal:  Curr Rheumatol Rep       Date:  2011-04       Impact factor: 4.592

4.  [Hyperuricemia and gout: diagnosis and therapy].

Authors:  A K Tausche; S Unger; K Richter; C Wunderlich; J Grässler; B Roch; H E Schröder
Journal:  Internist (Berl)       Date:  2006-05       Impact factor: 0.743

Review 5.  The Impacts of Serum Uric Acid on arterial hemodynamics and Cardiovascular Risks.

Authors:  Pai-Feng Hsu; Shao-Yuan Chuang; Wen-Chung Yu; Hsin-Bang Leu; Wan-Leong Chan; Chen-Huan Chen
Journal:  Acta Cardiol Sin       Date:  2013-03       Impact factor: 2.672

6.  Ischemia heart disease and greater waist circumference are risk factors of renal function deterioration in male gout patients.

Authors:  Ben Yu-Jih Su; Han-Ming Lai; Chung-Jen Chen; Ying-Chou Chen; Chun-Kai Chiu; Ko-Ming Lin; Shan-Fu Yu; Tien-Tsai Cheng
Journal:  Clin Rheumatol       Date:  2007-11-20       Impact factor: 2.980

7.  Lesch-Nyhan syndrome presenting with acute renal failure in a 3-day-old newborn.

Authors:  Ivana Pela; Maria Alice Donati; Elena Procopio; Patrizio Fiorini
Journal:  Pediatr Nephrol       Date:  2007-08-16       Impact factor: 3.714

Review 8.  The epidemiology and treatment of gout.

Authors:  Neil W McGill
Journal:  Open Access Rheumatol       Date:  2011-12-20

9.  Serum Uric Acid Concentration in Patients with Cerebrovascular Disease (Ischemic Stroke and Vascular Dementia).

Authors:  Nafija Serdarevic; Adina Elena Stanciu; Lejla Begic; Snezana Uncanin
Journal:  Med Arch       Date:  2020-04

10.  Rhabdomyolysis following status epilepticus with hyperuricemia: A case report and literature review.

Authors:  Lingxing Wang; Shanyan Hong; Honghong Huang; Meili Yang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.